We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
Advice on the use of puberty suppressants in the care of trans and gender diverse people aged under 18 is now available for public consultation.
Public consultation on the Advice on the use of puberty suppressants in the care of trans and gender diverse people aged under 18 (Advice on Puberty Suppressants) opens at 1 pm AEDT Monday 16 November 2026 and closes at 1 pm AEDT Monday 18 January 2027.
The Advice on Puberty Suppressants is available for download below, or on MagicApp (see Accessing documents, below).
Submissions should be made via the NHMRC Consultation Hub.
Submissions should address the content of the Advice on Puberty Suppressants, including the proposed recommendation and good practice statements, the interpretation of the evidence in the Advice on Puberty Suppressants, implementation considerations, and any other matters directly relevant to the Advice on Puberty Suppressants.
There are 13 background questions (Questions 2 to 14) and 5 questions related specifically to the Advice on Puberty Suppressants (Questions 15 to 18). You do not have to respond to all questions. There is a 500-word limit for questions relating specifically to the Advice on Puberty Suppressants. Any other comments about the Advice on Puberty Suppressants can be provided in Question 19 which has a 1,000 word limit. There will not be an opportunity to upload documents as part of your submission.
The Advice on Puberty Suppressants is available for public consultation below, and on MAGICapp.
To access MAGICapp on your tablet, phone, or computer:
Documents supporting the Advice on Puberty Suppressants, including the evidence evaluation report, technical report, and administrative report are also available for download below.
This public consultation on the Advice on Puberty Suppressants is the first of two public consultation opportunities in relation to developing the full national clinical guidelines for the care of trans and gender diverse people aged under 18.
Feedback provided through this consultation will be considered as part of developing the full guidelines, which will be available for public consultation by early 2028.
If you have any questions relating to public consultation or need further information while the consultation is open, please email consultation.genderguidelines@nhmrc.gov.au.
If you or anyone you know needs help: